PortfoliosLab logoPortfoliosLab logo
BME.L vs. EXAS
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

BME.L vs. EXAS - Performance Comparison

The chart below illustrates the hypothetical performance of a £10,000 investment in B&M European Value Retail SA (BME.L) and Exact Sciences Corporation (EXAS). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Different Trading Currencies

BME.L is traded in GBp, while EXAS is traded in USD. To make them comparable, the EXAS values have been converted to GBp using the latest available exchange rates.

Returns By Period


BME.L

1D
6.55%
1M
19.38%
YTD
23.34%
6M
24.86%
1Y
-21.90%
3Y*
-21.75%
5Y*
-11.06%
10Y*
2.22%

EXAS

1D
1M
YTD
6M
1Y
3Y*
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

BME.L vs. EXAS - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
BME.L
B&M European Value Retail SA
23.34%-48.93%-29.37%46.22%-32.26%36.96%36.07%48.71%-32.24%55.09%
EXAS
Exact Sciences Corporation
3.76%67.87%-22.72%41.96%-28.82%-40.70%39.06%40.99%27.22%259.26%

Correlation

The correlation between BME.L and EXAS is 0.03, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.03

Correlation (3Y)
Calculated over the trailing 3-year period

0.05

Correlation (5Y)
Calculated over the trailing 5-year period

0.07

Correlation (10Y)
Calculated over the trailing 10-year period

0.10

Correlation (All Time)
Calculated using the full available price history since Jun 13, 2014

0.10

Fundamentals

Market Cap

BME.L:

£2.09B

EXAS:

$19.91B

EPS

BME.L:

£0.48

EXAS:

-$1.10

PS Ratio

BME.L:

0.18

EXAS:

6.12

PB Ratio

BME.L:

2.62

EXAS:

8.29

Total Revenue (TTM)

BME.L:

£11.35B

EXAS:

$3.25B

Gross Profit (TTM)

BME.L:

£3.95B

EXAS:

$2.26B

EBITDA (TTM)

BME.L:

£1.54B

EXAS:

$42.61M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

BME.L vs. EXAS — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BME.L
BME.L Risk / Return Rank: 2424
Overall Rank
BME.L Sharpe Ratio Rank: 2121
Sharpe Ratio Rank
BME.L Sortino Ratio Rank: 2222
Sortino Ratio Rank
BME.L Omega Ratio Rank: 2222
Omega Ratio Rank
BME.L Calmar Ratio Rank: 2525
Calmar Ratio Rank
BME.L Martin Ratio Rank: 2929
Martin Ratio Rank

EXAS
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BME.L vs. EXAS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for B&M European Value Retail SA (BME.L) and Exact Sciences Corporation (EXAS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


BME.LEXASDifference
Sharpe ratioReturn per unit of total volatility

Sortino ratioReturn per unit of downside risk

Omega ratioGain probability vs. loss probability

0.95

Calmar ratioReturn relative to maximum drawdown

-0.49

Martin ratioReturn relative to average drawdown

-0.68

BME.L vs. EXAS - Sharpe Ratio Comparison


Loading charts...

Sharpe Ratios by Period


BME.LEXASDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.48

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.32

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.07

Sharpe Ratio (All Time)

Calculated using the full available price history

0.08

Drawdowns

BME.L vs. EXAS - Drawdown Comparison


Loading charts...

Drawdown Indicators


BME.LEXASDifference

Max Drawdown

Largest peak-to-trough decline

-70.05%

Max Drawdown (1Y)

Largest decline over 1 year

-45.55%

Max Drawdown (3Y)

Largest decline over 3 years

-70.05%

Max Drawdown (5Y)

Largest decline over 5 years

-70.05%

Max Drawdown (10Y)

Largest decline over 10 years

-70.05%

Current Drawdown

Current decline from peak

-59.30%

Average Drawdown

Average peak-to-trough decline

-17.83%

Ulcer Index

Depth and duration of drawdowns from previous peaks

32.39%

Volatility

BME.L vs. EXAS - Volatility Comparison


Loading charts...

Volatility by Period


BME.LEXASDifference

Volatility (1M)

Calculated over the trailing 1-month period

17.69%

Volatility (6M)

Calculated over the trailing 6-month period

31.39%

Volatility (1Y)

Calculated over the trailing 1-year period

48.69%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

34.34%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

31.03%

Dividends

BME.L vs. EXAS - Dividend Comparison

BME.L's dividend yield for the trailing twelve months is around 6.34%, while EXAS has not paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
BME.L
B&M European Value Retail SA
6.34%16.71%9.51%6.19%4.01%9.94%4.78%1.86%2.66%1.49%5.43%1.44%
EXAS
Exact Sciences Corporation
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

BME.L vs. EXAS - Financials Comparison

This section allows you to compare key financial metrics between B&M European Value Retail SA and Exact Sciences Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


500.00M1.00B1.50B2.00B2.50B3.00B20222023202420252026
3.03B
878.38M
(BME.L) Total Revenue
(EXAS) Total Revenue
Please note, different currencies. BME.L values in GBp, EXAS values in USD

BME.L vs. EXAS - Profitability Comparison

The chart below illustrates the profitability comparison between B&M European Value Retail SA and Exact Sciences Corporation over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

30.0%40.0%50.0%60.0%70.0%20222023202420252026
31.4%
70.1%
Portfolio components
BME.L - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, B&M European Value Retail SA reported a gross profit of 950.00M and revenue of 3.03B. Therefore, the gross margin over that period was 31.4%.

EXAS - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Exact Sciences Corporation reported a gross profit of 615.83M and revenue of 878.38M. Therefore, the gross margin over that period was 70.1%.

BME.L - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, B&M European Value Retail SA reported an operating income of 248.00M and revenue of 3.03B, resulting in an operating margin of 8.2%.

EXAS - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Exact Sciences Corporation reported an operating income of -76.68M and revenue of 878.38M, resulting in an operating margin of -8.7%.

BME.L - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, B&M European Value Retail SA reported a net income of 111.00M and revenue of 3.03B, resulting in a net margin of 3.7%.

EXAS - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Exact Sciences Corporation reported a net income of -85.96M and revenue of 878.38M, resulting in a net margin of -9.8%.


Frequently Asked Questions


BME.L and EXAS have a correlation of 0.03, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Portfolio Optimizer

Find the right allocation for BME.L and EXAS

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer